Our group has developed a new multiparametric highresolution flow cytometry (HRFC) method that can reliably identify, quantitate, and purify cell-and size-specific extracellular vesicles (EVs). We have also developed FITC-conjugated 100nm sized liposomes for HRFC sorting to control for potential plasma contamination "hitch-hikers" for proteomic and transcriptomic analysis. STUDY DESIGN: Prospective HRFC study of maternal plasma collected from n¼72 women in the first trimester (6-12 weeks) and 22 nonpregnant negative controls was used to visualize and sort placentalspecific EVs (PLAP+) using a modified FACSAria Fusion (BD Biosciences). Submicron beads (100, 160, 200, 240, 300, 500, 900nm) were used as sizing controls. Known quantities of 200nm beads were used as concentration controls to normalize between samples. EV size-and cell-type were confirmed by nano-particle tracking analysis (NTA), electron microscopy, and biomarker enrichment. Similarly, plasma samples were "spiked" with 10 ˇ 7 /ml FITC-conjugated liposomes, which were simultaneously sorted to control for any plasma contamination related to the EV isolation procedure. Samples of the 0.1um filtered PBS flow buffer, sorted liposomes (10^6/ml), and sorted PLAP+ exosomes from 6 and 12 weeks gestation were used for miRNA qRT-PCR analysis. miRNA extracted from first trimester placenta, and plasma samples from first trimester study subjects, served as positive controls. RESULTS: Placental PLAP+ exosomes may be readily sorted from first trimester plasma by HRFC with 100ul of plasma yielding 10 ˇ 6 EVs. miRNA yields from 0.1 um filtered PBS or sorted liposome negative controls were similar yielding 500pg/ml, or 10^6 sorted liposomes. Plasma yielded 2500 pg/ml; whereas, sorted PLAP+ EVs from 100ul of the same plasma yielded 500-750 pg per 10^6 events. Pilot qRT-PCR confirmed increased hypoxia related miRNAs in sorted EVs from 6 weeks' compared with 12 weeks' gestation. CONCLUSION: HRFC provides a new approach for placental-specific EV isolation from maternal plasma. Simultaneous sorting of placental EVs and 100nm liposome controls from plasma samples provides a useful negative control to exclude miRNA:protein "Argonaut" contamination in subsequent miRNA quantitation and qRT-PCR analysis.
OBJECTIVE:
Our group has developed a new multiparametric highresolution flow cytometry (HRFC) method that can reliably identify, quantitate, and purify cell-and size-specific extracellular vesicles (EVs). We have also developed FITC-conjugated 100nm sized liposomes for HRFC sorting to control for potential plasma contamination "hitch-hikers" for proteomic and transcriptomic analysis. STUDY DESIGN: Prospective HRFC study of maternal plasma collected from n¼72 women in the first trimester (6-12 weeks) and 22 nonpregnant negative controls was used to visualize and sort placentalspecific EVs (PLAP+) using a modified FACSAria Fusion (BD Biosciences). Submicron beads (100, 160, 200, 240, 300, 500, 900nm) were used as sizing controls. Known quantities of 200nm beads were used as concentration controls to normalize between samples. EV size-and cell-type were confirmed by nano-particle tracking analysis (NTA), electron microscopy, and biomarker enrichment. Similarly, plasma samples were "spiked" with 10 ˇ 7 /ml FITC-conjugated liposomes, which were simultaneously sorted to control for any plasma contamination related to the EV isolation procedure. Samples of the 0.1um filtered PBS flow buffer, sorted liposomes (10^6/ml), and sorted PLAP+ exosomes from 6 and 12 weeks gestation were used for miRNA qRT-PCR analysis. miRNA extracted from first trimester placenta, and plasma samples from first trimester study subjects, served as positive controls. RESULTS: Placental PLAP+ exosomes may be readily sorted from first trimester plasma by HRFC with 100ul of plasma yielding 10 ˇ 6 EVs. miRNA yields from 0.1 um filtered PBS or sorted liposome negative controls were similar yielding 500pg/ml, or 10^6 sorted liposomes. Plasma yielded 2500 pg/ml; whereas, sorted PLAP+ EVs from 100ul of the same plasma yielded 500-750 pg per 10^6 events. Pilot qRT-PCR confirmed increased hypoxia related miRNAs in sorted EVs from 6 weeks' compared with 12 weeks' gestation. CONCLUSION: HRFC provides a new approach for placental-specific EV isolation from maternal plasma. Simultaneous sorting of placental EVs and 100nm liposome controls from plasma samples provides a useful negative control to exclude miRNA:protein "Argonaut" contamination in subsequent miRNA quantitation and qRT-PCR analysis.
116 The cost-effectiveness of various fetal surveillance strategies in pregnancies complicated by advanced maternal age James Sargent, Ashley Skeith, Aaron Caughey OHSU, Portland, OR OBJECTIVE: Advanced maternal age is associated with an increased incidence of intrauterine fetal demise (IUFD). Various strategies of antepartum surveillance have been proposed to decrease the incidence of IUFD, however these are associated with increased medical interventions. We designed a model to examine the cost-effectiveness of various antepartum surveillance strategies. STUDY DESIGN: A decision-analytic model with a Markov process was built using TreeAge Pro and incorporated probabilities, costs, and utilities from the literature. We compared the strategies of -starting at 37 weeks gestation -two times weekly non-stress testing (NST), one time weekly NST, and no scheduled antenatal surveillance. We assumed that a non-reactive NST was followed by a biophysical profile (BPP) and then either delivery or return to scheduled surveillance. This model was then applied to a theoretical cohort of 100,000 women, the cost-effectiveness threshold was set to $100,000 per quality-adjusted life year (QALY), and the robustness of the model was assessed with sensitivity analysis. RESULTS: In our model, two times weekly NST resulted in 34,304 positive tests and 487 indicated deliveries, which was 232 more then the one time weekly strategy. The two times weekly strategy resulted in 53 fewer IUFDs compared to the no additional surveillance strategy and 18 fewer IUFDs then the one time weekly strategy (table). In one-way sensitivity analysis, the two times weekly strategy was the cost-effective option up to a NST cost of $357, and up to a BPP cost of $4,418. The two times weekly strategy was the costeffective strategy with an ICER of $36,610. CONCLUSION: In pregnancies complicated by advanced maternal age, two times weekly NST is the cost-effective strategy resulting in decreased IUFDs at the expense of increased medical interventions. 
